Trulieve Cannabis Corp.
TCNNF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,186,490 | $1,129,193 | $1,239,800 | $938,385 |
| % Growth | 5.1% | -8.9% | 32.1% | – |
| Cost of Goods Sold | $470,745 | $540,565 | $557,800 | $372,255 |
| Gross Profit | $715,745 | $588,628 | $682,000 | $566,130 |
| % Margin | 60.3% | 52.1% | 55% | 60.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $252,735 | $145,997 | $169,700 | $100,573 |
| SG&A Expenses | $510,451 | $386,162 | $454,600 | $315,717 |
| Sales & Mktg Exp. | $257,716 | $240,165 | $284,900 | $215,144 |
| Other Operating Expenses | $107,514 | $424,079 | $119,400 | $48,096 |
| Operating Expenses | $617,965 | $810,241 | $574,000 | $363,813 |
| Operating Income | $97,780 | -$221,613 | $109,400 | $196,946 |
| % Margin | 8.2% | -19.6% | 8.8% | 21% |
| Other Income/Exp. Net | -$55,066 | -$62,924 | -$69,403 | -$27,804 |
| Pre-Tax Income | $42,714 | -$284,537 | -$43,300 | $163,506 |
| Tax Expense | $197,589 | $151,358 | $161,800 | $146,061 |
| Net Income | -$155,105 | -$526,796 | -$205,100 | $18,032 |
| % Margin | -13.1% | -46.7% | -16.5% | 1.9% |
| EPS | -0.82 | -2.84 | -1.1 | 0.13 |
| % Growth | 71.1% | -158.2% | -946.2% | – |
| EPS Diluted | -0.82 | -2.84 | -1.09 | 0.12 |
| Weighted Avg Shares Out | 189,993 | 188,974 | 187,266 | 142,651 |
| Weighted Avg Shares Out Dil | 189,993 | 188,974 | 187,995 | 146,757 |
| Supplemental Information | – | – | – | – |
| Interest Income | $14,678 | $6,164 | $1,631 | $205 |
| Interest Expense | $62,193 | $81,569 | $73,422 | $29,121 |
| Depreciation & Amortization | $166,369 | $169,911 | $185,569 | $78,220 |
| EBITDA | $258,857 | -$33,057 | $239,753 | $283,588 |
| % Margin | 21.8% | -2.9% | 19.3% | 30.2% |